The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,228.00
Bid: 12,224.00
Ask: 12,228.00
Change: -18.00 (-0.15%)
Spread: 4.00 (0.033%)
Open: 12,240.00
High: 12,306.00
Low: 12,132.00
Prev. Close: 12,246.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Caution prevails in world markets ahead of Fed

Wed, 17th Mar 2021 09:40

* Investors watching for signs of faster policy
normalisation

* Fed statement due at 1800 GMT

* European shares open weaken

* Graphic: Global asset performance http://tmsnrt.rs/2yaDPgn

* Graphic: World FX rates http://tmsnrt.rs/2egbfVh

By Dhara Ranasinghe

LONDON, March 17 (Reuters) - Caution descended on markets on
Wednesday with world stocks holding below recent record highs as
investors waited to see whether the U.S. Federal Reserve would
signal a faster path toward policy normalisation than previously
expected.

The U.S. central bank ends a closely anticipated two-day
meeting later in the day, after a sharp rise in U.S. Treasury
yields this year on expectations for stronger growth and
inflation.

The Fed is expected to forecast that the U.S. economy will
grow in 2021 at the fastest rate in decades. But investors who
expect rosier projections to translate to any change in monetary
policy will probably be disappointed.

"This is one of the most important Fed meetings we've had
for some time and the impact will be felt across asset classes,"
said Seema Shah, chief strategist at Principal Global Investors.

"Markets are hoping for reassurance from the Fed that rising
bond yields are not something to worry about, and that takes a
bit of steam out of the bond market."

Before the Fed statement at 1800 GMT, calm prevailed across
world markets.

MSCI's world equity index was down 0.1%, but
keeping last month's record highs within sight.

European shares were a touch softer ,
while in Asia, an index of regional equities excluding Japan
pulled back 0.4%. Japan's Nikkei 225
closed flat.

There was some good news for AstraZeneca as
Australia's pharmaceutical regulator said the rollout of the
company's COVID-19 vaccine would continue, even though many
European nations have paused vaccinations to investigate
reported side-effects.

U.S. stock futures pointed to a flat open on Wall
Street, after the S&P 500 lost 0.16% on Tuesday.

DOVISH?

Benchmark 10-year Treasury yields were a touch
higher at 1.63%, holding near 13-month highs reached on Friday.
They have risen 72 basis points so far this year. That compares
with a 24 bps increase in German peers and a 7 bps
rise in Japanese borrowing costs.

Inflation expectations have also ticked higher with the
break-even rate on 10-year Treasury Inflation-Protected
Securities (TIPS) on Tuesday rising above 2.3% for
the first time since July 2014. The break-even rate for 30-year
TIPS hit 2.24%, the highest since September 2014.

"We expect (Fed Chair Jerome) Powell to note the FOMC has
the tools to intervene if the bond market becomes disorderly or
constrains the economic recovery," analysts at Commonwealth Bank
of Australia wrote.

"But we expect Powell to push back against talk of policy
tightening because of the large amount of labour market slack
... U.S. bond yields and the U.S. dollar could jump if the
FOMC’s post-meeting statement and Powell’s statement are not
deemed dovish enough."

An index tracking the dollar against six major peers
was around 91.92. The euro was weaker on the day at $1.1892
. The dollar was up about 0.1% at 109.13 yen.

Currency market caution may extend all week, with the Bank
of England meeting on Thursday and the Bank of Japan wrapping up
a policy review on Friday, in which it may phase out a numerical
target for its asset buying.

Elsewhere, oil prices slipped for a fourth day as concern
about weaker demand in Europe outweighed an industry report that
showed U.S. crude stockpiles unexpectedly fell last week.

Brent crude futures fell 27 cents to $68.12 a barrel
and U.S. crude futures slipped 14 cents to $64.65.

For Reuters Live Markets blog on European and UK stock
markets, please click on:

(Reporting by Dhara Ranasinghe; Additional reporting by Kevin
Buckland in Tokyo; editing by Larry King)

More News
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.